COVID-19 vaccinations summary

Second Boosters Administered 981,872
Total Doses Administered 12,663,641
First Boosters Administered 2,773,181
Percentage of 12+ who have completed primary course 90.1%
Percentage of eligible 50+ who have received second booster 55.1%
Percentage of eligible 18+ who have received first booster 73.0%

 

Metrics on this page can use one of two views of the data. An operational view or a person view. There are two main differences between the views which result in slightly different totals.

  • Occasionally doses that are recorded as first doses in CIR are actually a person's second doses. This means they will appear as dose 1 in the operational view but will appear as completed primary course in the person view (this is a data entry issue only and does not impact the dose that the person received).
  • Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

In short, the operational view shows how doses administered in New Zealand were recorded in CIR. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand.

Total Vaccinations

  Vaccinations last week Cumulative total
First dose 13 4,032,019
Second dose 23 3,985,233
Third primary 1 34,660
Booster 1 194 2,773,181
Booster 2 1,120 981,872
Booster 3 1,777 425,946
Paediatric First Dose 16 271,669
Paediatric Second Dose 14 158,246
Infant First Dose 1 138
Infant Second Dose 1 112
Infant Third Dose 1 62
Total doses 3,201 12,663,641

This table is an operational view.

Definitions

  • Cumulative total: All vaccinations that have been administered and entered into the COVID-19 Immunisation Register and including Friday 22 September 2023.
  • Vaccinations last week:  Over the 7 days up to and including Friday 22 September 2023.

Booster breakdowns

Booster counts by ethnicity

Ethnicity Booster 1 (16-17) Booster 1 (18+) Booster 2 (50+)
Māori 1,075 254,579 61,629
Pacific Peoples 724 154,935 27,143
Asian 2,165 460,912 59,601
European/Other 6,432 1,825,197 668,704
Unknown 33 19,370 3,667
Total 10,429 2,714,993 820,744

This table is a person view.

Booster 2 uptake by age group

Age Group Eligible Received Uptake
12 to 17 - 150 -
18 to 34 - 34,628 -
35 to 49 634,946 109,452 -
50 to 64 730,037 280,813 38.5%
65+ 758,704 539,931 71.2%

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand. A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered. A graph showing where the most COVID vaccines are being administered.

Note, this figure does not include 5-11 year olds

* Note, this figure does not include 5-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week. A graph showing how many COVID vaccinations are happening each week.

This chart shows the count of vaccinations administered in a given week from the COVID-19 Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.
 

View Medsafe data on COVID-19 vaccine adverse effects following immunisation